About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Metabolic Activity Inhibitors for Treating HIV

by Ramya Rachamanti on December 26, 2018 at 11:10 AM
Font : A-A+

Metabolic Activity Inhibitors for Treating HIV

Current antiretroviral therapy has to be taken life long as it is unable to eliminate viral reservoirs. Metabolic activity inhibitors which destroy these reservoirs were identified by the scientists of Institut Pasteur basing on the characteristics of CD4 T lymphocytes that are specifically infected by the virus. Their findings were published in the journal Cell Metabolism.

The antiretroviral treatment used today is designed to block HIV infection but it is not able to eliminate the virus from the body. The virus remains in reservoirs - the CD4 T lymphocyte immune cells, the main targets of HIV. However, the virus does not infect all types of CD4 cell and until now the reason for this was not well known.

Advertisement


In this study, scientists from the HIV, Inflammation and Persistence Unit at the Institut Pasteur and colleagues have identified the characteristics of the different CD4 subpopulations, which are associated with HIV infection.

The more the CD4 cells are differentiated, or experienced, the more they need to produce energy to perform their function. Experiments have shown that it is the metabolic activity of the cell, and in particular its glucose consumption, that plays a key role in susceptibility to HIV infection. The virus primarily targets cells with high metabolic activity. To multiply, it hijacks the energy and products provided by the cell.
Advertisement

This requirement constitutes a weakness for the virus and could be exploited to tackle infected cells. Scientists succeeded in blocking the infection ex vivo thanks to metabolic activity inhibitors that have already been investigated in cancer research.

"We have observed ex vivo that, thanks to certain metabolic inhibitors, the virus is no longer able to infect cells and amplification is halted in reservoirs of patients receiving antiretroviral treatment."



Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest AIDS/HIV News

Are Countries Missing on HIV Self-Testing?
Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.
 Monthly Vaginal Ring Prevents HIV During Breastfeeding Safely
How can you prevent HIV while breastfeeding? A monthly vaginal ring containing the antiretroviral drug dapivirine safely prevents HIV infection while breastfeeding.
De-stigmatizing Move Against HIV
Union Minister of State for Health Bharti Pravin Pawar had said that the government is providing free lifelong antiretroviral (ARV) medicines for people living with HIV.
Are we on the Right Track to End AIDS by 2030
Dr. Korosi said the goal to end AIDS by 2030 is badly off track, as inequalities, discrimination, and disregard for human rights are hampering our progress.
World AIDS Day 2022: Let's Address Inequalities that Fuel HIV
In accordance with the Sustainable Development Goals, India is committed to 'Ending the AIDS' epidemic as a public health threat by 2030.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Metabolic Activity Inhibitors for Treating HIV Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests